What is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for a wide array of diseases in the world, including cancers, immune-related diseases, infectious diseases, and hematological diseases1. Over half target membrane proteins, primarily proteins with large extracellular domains and simple transmembrane domains such as tyrosine…
Validatable Band Sealers for Medical Pouches
By Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY. The customer’s level of confidence and trust is everything. This especially occurs when supplying pouch-sealing machinery for the medical and pharmaceutical industry. I have been taught to evaluate the application and discuss the features of the validation medical pouch-sealing machinery side-by-side to the…
Raumedic: A Trusted Partner in Serving the Pharmaceutical Industry with the Gold Standard in Silicone Tubing
Raumedic is a trusted partner in the international medical technology and pharmaceutical industry. The medical division of the global corporation REHAU, a family-owned company, has over 70 years of tried and trusted experience in extrusion, injection molding and assembly. With a focus on developing and manufacturing components for a diverse range of diagnostic and therapeutic…
The Evolution of Heat Sealing
by Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has evolved over many decades to reduce cost and increase profit with precision heat sealing. This article reflects on these advancements and how to obtain perfect seals every time. In recent years the methods and means of cutting and/or sealing plastic films and joining…
A new way to access scientific papers?
Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to find that leaving university also means leaving behind something they didn’t expect—easy access to peer-reviewed literature. Especially for those who have gone to work at startups or other smaller organizations, finding a way to do…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA Assays
By Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing number of pharmaceutical companies seeking more drug modalities to extend their pipelines. Additionally, biosimilars now have more opportunities to enter the market as patents of some blockbuster monoclonal antibodies begin to expire. Given this context,…
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug therapies By Tim McLeroy, Executive Director of Marketing & Patient Services The global market for medical devices is approximately $436 billion, bolstered by an aging population, according to data from hfMEDIC, the University of Utah-led…